Unexpected Biotransformation of the HDAC Inhibitor Vorinostat Yields Aniline-Containing Fungal Metabolites

ACS Chemical Biology
Donovon A AdpressaSandra Loesgen

Abstract

The diversity of genetically encoded small molecules produced by filamentous fungi remains largely unexplored, which makes these fungi an attractive source for the discovery of new compounds. However, accessing their full chemical repertoire under common laboratory culture conditions is a challenge. Epigenetic manipulation of gene expression has become a well-established tool for overcoming this obstacle. Here, we report that perturbation of the endophytic ascomycete Chalara sp. 6661, producer of the isofusidienol class of antibiotics, with the HDAC inhibitor vorinostat resulted in the production of four new modified xanthones. The structures of chalanilines A (1) and B (2) and adenosine-coupled xanthones A (3) and B (4) were determined by extensive NMR spectroscopic analyses, and the bioactivities of 1-4 were tested in antibiotic and cytotoxicity assays. Incorporation studies with deuterium-labeled vorinostat indicate that the aniline moiety in chalalanine A is derived from vorinostat itself. Our study shows that Chalara sp. is able to metabolize the HDAC inhibitor vorinostat to release aniline. This is a rare report of fungal biotransformation of the popular epigenetic modifier vorinostat into aniline-containing polyketides.

References

Sep 27, 2002·Chembiochem : a European Journal of Chemical Biology·Helge Björn BodeAxel Zeeck
Dec 29, 2004·Journal of Natural Products·Mark S Butler
Aug 30, 2005·Journal of Natural Products·Jixun Zhan, A A Leslie Gunatilaka
Jun 27, 2006·Nature Chemical Biology·Kenji WatanabeHideaki Oikawa
Jul 11, 2006·Magnetic Resonance in Chemistry : MRC·Rohan A Davis, Gregory K Pierens
May 16, 2008·Organic & Biomolecular Chemistry·Russell B WilliamsRobert H Cichewicz
Dec 19, 2008·Chembiochem : a European Journal of Chemical Biology·Sabine GrüschowRebecca J M Goss
Jul 11, 2009·Organic & Biomolecular Chemistry·Kirstin Scherlach, Christian Hertweck
May 4, 2010·Fungal Genetics and Biology : FG & B·Axel A Brakhage, Volker Schroeckh
Oct 23, 2012·Methods in Enzymology·Fang Yun LimNancy P Keller
Oct 23, 2013·Journal of Industrial Microbiology & Biotechnology·Philipp Wiemann, Nancy P Keller
Jun 30, 2015·Nature Reviews. Microbiology·Peter J Rutledge, Gregory L Challis
Sep 16, 2015·Proceedings of the National Academy of Sciences of the United States of America·Kenji L KuritaRoger G Linington
Sep 30, 2015·Chembiochem : a European Journal of Chemical Biology·Juliane KorpMarkus Nett
Feb 18, 2016·Chemistry & Biodiversity·Donovon A Adpressa, Sandra Loesgen
Sep 13, 2016·Persoonia·P W CrousJ Z Groenewald

❮ Previous
Next ❯

Citations

Apr 14, 2018·Science Advances·Colin J B HarveyMaureen E Hillenmeyer
Jan 8, 2020·Critical Reviews in Biotechnology·Huaxiang DengYujie Cai
May 18, 2021·The Journal of Organic Chemistry·Mahsa KhoshbakhtPaul R Blakemore
Aug 8, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Mahsa KhoshbakhtSandra Loesgen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.